Public policy

Full Answer Section

      Why Cost-Effectiveness Analysis?

• Balancing Costs and Benefits: Healthcare resources are finite. It's crucial to evaluate if the potential benefits of a policy justify its associated costs. Cost-effectiveness analysis considers both factors, providing valuable insights for policymakers.
• Prioritization: With numerous proposals for addressing drug pricing, policymakers need a framework to compare options. Cost-effectiveness analysis allows for an objective comparison of the costs and health benefits of various policy interventions.
• Long-Term Impact: This analysis considers not just immediate costs, but also long-term societal costs associated with untreated illnesses. For example, a policy that reduces medication costs for diabetes patients could lead to better disease management, potentially reducing future healthcare expenses related to complications.

By applying a cost-effectiveness analysis, policymakers can assess:

• The impact of the policy on medication affordability and adherence.
• The potential cost savings to the healthcare system through improved health outcomes.
• The long-term economic benefits of a healthier population.

Additional Considerations: While cost-effectiveness analysis is valuable, it's important to acknowledge limitations. It may not fully capture ethical considerations or the value of improved quality of life for patients. Policymakers should consider this criterion alongside other factors like social equity and ethical implications when making final decisions. Conclusion: The high cost of prescription drugs demands effective policy solutions. Cost-effectiveness analysis equips policymakers with a framework to evaluate interventions based on their impact on both costs and health outcomes, ultimately promoting a more efficient and equitable healthcare system.  

Sample Answer

   

Public Policy Issue: The High Cost of Prescription Drugs in the United States

Criterion for Policy Prescription: Cost-Effectiveness Analysis

The high cost of prescription drugs in the United States is a major public policy concern. Many Americans struggle to afford essential medications, leading to non-adherence and potentially worse health outcomes.